Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-14
DOI
10.1038/s41598-021-89827-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY
- (2020) Alan J. Garber et al. Endocrine Practice
- Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administration
- (2020) Macarena Ortiz et al. DIGESTIVE AND LIVER DISEASE
- Docosahexaenoic Acid Inhibits Inflammation-Induced Osteoclast Formation and Bone Resorption in vivo Through GPR120 by Inhibiting TNF-α Production in Macrophages and Directly Inhibiting Osteoclast Formation
- (2019) Akiko Kishikawa et al. Frontiers in Endocrinology
- Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis
- (2019) Alexander Rauch et al. NATURE GENETICS
- Overview of RAW264.7 for osteoclastogensis study: Phenotype and stimuli
- (2019) Lingbo Kong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approach
- (2019) Sandra A. Soto‐Alarcón et al. BIOFACTORS
- Bone Benefits of Fish Oil Supplementation Depend on its EPA and DHA Content
- (2019) Haissam Abou-Saleh et al. Nutrients
- Thiazolidinediones as antidiabetic agents: A critical review
- (2018) M.J. Nanjan et al. BIOORGANIC CHEMISTRY
- Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities
- (2018) Jacques Galipeau et al. Cell Stem Cell
- Free Fatty Acid Receptor 4 (GPR120) Stimulates Bone Formation and Suppresses Bone Resorption in the Presence of Elevated n-3 Fatty Acid Levels
- (2016) Seong Hee Ahn et al. ENDOCRINOLOGY
- Pioglitazone and Risk for Bone Fracture: Safety Data from a Randomized Clinical Trial
- (2016) Catherine M. Viscoli et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
- (2016) Walter N. Kernan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-chain polyunsaturated fatty acids regulation of PPARs, signaling: Relationship to tissue development and aging
- (2016) Francisca Echeverría et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences
- (2016) Giuseppina T. Russo et al. International Journal of Endocrinology
- The Impact of Diabetes and Diabetes Medications on Bone Health
- (2015) Matthew P. Gilbert et al. ENDOCRINE REVIEWS
- GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs
- (2015) Bo Gao et al. Scientific Reports
- Cancer and bone fractures in observational follow-up of the RECORD study
- (2014) Nigel P. Jones et al. ACTA DIABETOLOGICA
- DHA is a more potent inhibitor of breast cancer metastasis to bone and related osteolysis than EPA
- (2013) Md Mizanur Rahman et al. BREAST CANCER RESEARCH AND TREATMENT
- Conjugated Linoleic Acid Prevents Ovariectomy-Induced Bone Loss in Mice by Modulating Both Osteoclastogenesis and Osteoblastogenesis
- (2013) Md Mizanur Rahman et al. LIPIDS
- The Cardiovascular Safety of Diabetes Drugs — Insights from the Rosiglitazone Experience
- (2013) William R. Hiatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preservation of Metabolic Flexibility in Skeletal Muscle by a Combined Use of n-3 PUFA and Rosiglitazone in Dietary Obese Mice
- (2012) Olga Horakova et al. PLoS One
- N-3 Long-Chain Polyunsaturated Fatty Acid Supplementation Significantly Reduces Liver Oxidative Stress in High Fat Induced Steatosis
- (2012) Rodrigo Valenzuela et al. PLoS One
- Unmasking Differential Effects of Rosiglitazone and Pioglitazone in the Combination Treatment with n-3 Fatty Acids in Mice Fed a High-Fat Diet
- (2011) Vladimir Kus et al. PLoS One
- GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
- (2010) Da Young Oh et al. CELL
- Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice
- (2010) Ganesh V. Halade et al. EXPERIMENTAL GERONTOLOGY
- Endogenously produced n-3 fatty acids protect against ovariectomy induced bone loss in fat-1 transgenic mice
- (2010) Jameela Banu et al. JOURNAL OF BONE AND MINERAL METABOLISM
- t10c12-CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity
- (2010) Md M. Rahman et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Docosahexaenoic Acid-Enriched Fish Oil Attenuates Kidney Disease and Prolongs Median and Maximal Life Span of Autoimmune Lupus-Prone Mice
- (2010) G. V. Halade et al. JOURNAL OF IMMUNOLOGY
- Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice
- (2010) Ganesh V. Halade et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- THIAZOLIDINEDIONES INHIBIT TNF-α-MEDIATED OSTEOCLAST DIFFERENTIATION OF RAW264.7 MACROPHAGES AND MOUSE BONE MARROW CELLS THROUGH DOWNREGULATION OF NFATc1
- (2010) Chia-Ron Yang et al. SHOCK
- n-3 Fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet
- (2009) O. Kuda et al. DIABETOLOGIA
- Risk of Fractures with Glitazones
- (2009) Michael Bodmer et al. DRUG SAFETY
- Endogenous n-3 fatty acids protect ovariectomy induced bone loss by attenuating osteoclastogenesis
- (2009) Md Mizanur Rahman et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Bone loss in inflammatory disorders
- (2009) R Hardy et al. JOURNAL OF ENDOCRINOLOGY
- Differential effects of conjugated linoleic acid isomers in insulin-resistant female C57Bl/6J mice
- (2009) Ganesh V. Halade et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Fish Oil Fatty Acids as Cardiovascular Drugs
- (2008) Alexander Leaf et al. Current Vascular Pharmacology
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Effects of n-3 fatty acids on autoimmunity and osteoporosis
- (2008) Gabriel Fernandes Frontiers in Bioscience-Landmark
- The effect of thiazolidinediones on BMD and osteoporosis
- (2008) Allyson K McDonough et al. Nature clinical practice. Endocrinology & metabolism
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now